Jay is a co-founder of The Nashton Company. The Nashton Company is a holding company investing in recurring revenue services businesses. Nashton builds leading companies in niche markets over a very long period of time.
Prior to cofounding the firm, Jay served as the CEO of Vector Disease Acquisition, a holding company that provides vector-borne disease prevention programs and lake management services. Under Jay’s leadership, the company made 14 acquisitions and grew at a CAGR of 43%. Vector Disease Acquisition was acquired by Rentokil Initial (FTSE: RTO) in November of 2017.
Jay obtained a Master in Business Administration from Harvard Business School and graduated Phi Beta Kappa from Vanderbilt University with a degree in Economics.